The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Gendius developed product Intellin® is an intelligent diabetes management platform that uses clinical data to predict the trajectory of an individual's diabetes and helps to mitigate progression through smart tips. Powered by sophisticated AI algorithms, Intellin® is changing the way diabetes is managed. The Intellin® App is today the fastest downloaded diabetes app in the world.
Early detection of melanoma is crucial for disease prognosis and survival rate. The Primary Care Innovations Programme has partnered with Gnosco to implement and evaluate the Dermicus teledermatology Platform across all GP locations on the Isle of Wight.
Life QI's journey started when an early partnership was formed in 2015 with the South West of England Academic Health Science Network, in England with an aim to deliver an online platform that assisted frontline health and social care staff in running quality improvement (QI) projects. Levels of improvement work varied across a range of organisations with limited accessibility to the data. Staff became increasingly frustrated with using multiple, clunky software applications to record their quality improvement and patient safety work which identified a clear gap in the market for an all-in-one solution.
Pando is a communications platform for healthcare professionals, created by NHS doctors which helps NHS workers exchange patient information, make clinical decisions, manage their workload, and making collaboration easy, fast and secure. Pando saves healthcare professionals more than 40 minutes per shift and improves satisfaction at work, while saving NHS Trusts £6.9m over a 5-year term.
GripAble are developing gamified mobile technologies for therapy and assessment. Common equipment used for hand and arm therapy, such as thera-putty or stress balls, have not been successfully digitised. The company’s first product, GripAble™, is a digital handgrip that wirelessly connects to a mobile app, allowing patients to play fun therapy games. It has been designed to be highly portable and patient-personalised.
The PD Safe is designed to identify potentially fatal infection in dialysis patients. This Microbiosensor device is aimed at patients with kidney failure who are being treated using peritoneal dialysis therapy (PD) and acts as an early warning system for peritoneal infection.
A Liverpool-based company has developed and spread two apps among a number of health and care providers, and is co-creating four more following support from the Innovation Agency, the AHSN for the North West Coast.
Spirit Digital’s CliniTouch Vie platform uses remote monitoring to help patients self-manage conditions and enable healthcare teams to proactively monitor patients safely at their home or usual place of residence, enabling prioritised focus on those who need support. The platform supports pathways and conditions including Chronic Obstructive Pulmonary Disease (COPD), heart failure services, frailty patients and care home healthcare, and early discharge and post surgery services. The platform has been particularly relevant during the Covid-19 pandemic as COPD patients are in the high risk category.
Cambridge Respiratory Innovations (Camresp)
Camresp have developed a CE-marked, proprietary, CO2 sensing device named N-Tidal, which enables them to collect more data from normal breathing than ever before. The device provides new insights into lung function. The connected hand-held device is simple to use, requires little-to-no training and is perfect for use within the clinic or at home. It is suitable for patients as young as 4 years old as well as the elderly. With unique insights, as well as correlations to FEV1, PEF and FEV25-75, the N-Tidal brings a new paradigm in the diagnosis, monitoring and management of cardiorespiratory conditions.
Beringar has developed ground-breaking new technology that provides a comprehensive digital picture of how NHS buildings are being utilised. The system detects both human activity and equipment (location and movement). It also monitors eight different environmental factors to support better human-building interaction.
Oxford AHSN Strategyzer workshops helps companies shape their offering to be in-line with NHS needs
The Oxford AHSN Strategyzer half to one day workshops are run for companies that have a product or innovation and want to explore the viability of their concept for the NHS or want to move into the NHS market.
Diagnostic tests trialled in community hospital proved to ease winter pressure and increase efficiency
Wokingham Community Hospital purchased two different Point of Care (POC) diagnostic test devices for their elderly in-patient unit and wanted to evaluate the impact of attaining results more quickly and understand how it could help the nurses make effective decisions regarding treatment. The Oxford AHSN assisted by reporting the economic cost-consequence analysis of the two tests, determining what the cost benefit would be to the hospital by using Point of Care testing and extrapolate the benefits to the other community hospitals. QuickRead Go CRP is a rapid blood test for the quantitative determination of C-reactive protein that shows if there is inflammation or infection in the body. Alinity i-STAT is a portable blood testing machine with a cartridge for urea and electrolytes (U&E) that the nurses used to assess the kidney function of the patient. The tests enabled healthcare professionals to rapidly diagnose patients, and the greatest benefit came in knowing which patients did not need to be sent to the local Emergency Department (ED).